APA (7th ed.) Citation

WS, H., VR, D., AD, G., AW, G., LT, M., H, K., . . . J, H. (2024). Clinical validation of C12FDG as a marker associated with senescence and osteoarthritic phenotypes. Aging cell, 23(5), e14113. https://doi.org/10.1111/acel.14113

Chicago Style (17th ed.) Citation

WS, Hambright, et al. "Clinical Validation of C12FDG as a Marker Associated with Senescence and Osteoarthritic Phenotypes." Aging Cell 23, no. 5 (2024): e14113. https://doi.org/10.1111/acel.14113.

MLA (9th ed.) Citation

WS, Hambright, et al. "Clinical Validation of C12FDG as a Marker Associated with Senescence and Osteoarthritic Phenotypes." Aging Cell, vol. 23, no. 5, 2024, p. e14113, https://doi.org/10.1111/acel.14113.